Precipio Inc (PRPO NASDAQ) stock market data APIs
$14.72
1.43(9.7%)
as of July 14, 2025
Try our APIs with
free plan!
Precipio Inc Financial Data Overview
Price chart is built with
Anychart
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
Prev. Close
14.72
Open
16.1496
High
16.1496
Low
14.2258
52 wk Range
3.9-16.89
Market Cap
23 550 K
Shares Outstanding
1 512 K
Revenue
20 029 K
EPS
-0.5883
Beta
1.251
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Precipio Inc data using free add-ons & libraries
Get Precipio Inc Fundamental Data
Precipio Inc Fundamental data includes:
- Net Revenue: 20 029 K
- EBITDA: -1 667 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-12
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Precipio Inc News
New
Precipio amends warrant agreement, to receive $1.2M in cash
NEW HAVEN, Conn. - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), currently trading at $15.57 with a market capitalization of $23.14 million, announced Friday it has modified an ag...
Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless
NEW HAVEN, Conn., July 11, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has entered into an agreement with its largest warrant holder, amending the ex...
Arena Group Holdings vs. Precipio: 2 New Top 100 Stocks to Buy. Precipio’s the Buy.
Medicine labratory by gorodenkoff via iStock There were 10 new additions to Barchart’s Top 100 Stocks to Buy on Monday. Of the 10, Arena Group Holdings (AREN) and Precipio (PRPO) stand out among ...
The Zacks Analyst Blog Highlights Apple, Oracle, Goldman Sachs and Precipio
For Immediate Release Chicago, IL – July 7, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and ev...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
